Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system

被引:53
作者
Jordanova, ES [1 ]
Riemersma, SA
Philippo, K
Giphart-Gassler, M
Schuuring, E
Kluin, PM
机构
[1] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Radiat Genet & Chem Mutagenesis, NL-2333 ZA Leiden, Netherlands
关键词
D O I
10.1002/gcc.10093
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Loss of heterozygosity (LOH) is a major mechanism for inactivation of tumor-suppressor genes and has been observed in various solid tumors and lymphomas, The human leukocyte antigen (HLA) region is located at chromosome band 6p21.3, and loss or alteration of this region may provide tumor cells with a mechanism to escape from the immune system. We previously identified small homozygous deletions within the HLA class 11 region in many of the diffuse large B-cell lymphomas (DLCLs) of the central nervous system (CNS) and the testis. In the present study, we focused on the mechanism leading to LOH in the HLA region. Twenty microsatellite markers, of which 12 were specific for HLA, were applied on 11 extranodal DLCLs of the CNS and 28 of the testis. Additionally, fluorescence in situ hybridization with seven HLA-specific probes and a centromere 6-specific probe was performed on 20 cases to study the mechanism of LOH. In contrast to previously published data on spontaneously mutated lymphoblastoid cell lines, intrachromosomal hemizygous deletion, not mitotic recombination, was the major cause of LOH of the HLA region in these lymphomas. However, opposed to data in colorectal cancer. these deletions were rarely (one of nine cases) associated with an interchromosomal rearrangement such as a translocation. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:38 / 48
页数:11
相关论文
共 45 条
[1]   Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course [J].
Amiot, L ;
Onno, M ;
Lamy, T ;
Dauriac, C ;
Le Prise, PY ;
Fauchet, R ;
Drenou, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (04) :655-663
[2]   Comparative allelotyping of the short arm of human chromosome 3 in epithelial tumors of four different types [J].
Braga, E ;
Pugacheva, E ;
Bazov, I ;
Ermilova, V ;
Kazubskaya, T ;
Mazurenko, N ;
Kisseljov, F ;
Liu, J ;
Garkavtseva, R ;
Zabarovsky, E ;
Kisselev, L .
FEBS LETTERS, 1999, 454 (03) :215-219
[3]   Mechanisms of loss of HLA class I expression on colorectal tumor cells [J].
Browning, M ;
Petronzelli, F ;
Bicknell, D ;
Krausa, P ;
Rowan, A ;
Tonks, S ;
Murray, N ;
Bodmer, J ;
Bodmer, W .
TISSUE ANTIGENS, 1996, 47 (05) :364-371
[4]   FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS [J].
CAIRNS, P ;
POLASCIK, TJ ;
EBY, Y ;
TOKINO, K ;
CALIFANO, J ;
MERLO, A ;
MAO, L ;
HERATH, J ;
JENKINS, R ;
WESTRA, W ;
RUTTER, JL ;
BUCKLER, A ;
GABRIELSON, E ;
TOCKMAN, M ;
CHO, KR ;
HEDRICK, L ;
BOVA, GS ;
ISAACS, W ;
KOCH, W ;
SCHWAB, D ;
SIDRANSKY, D .
NATURE GENETICS, 1995, 11 (02) :210-212
[5]   HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas [J].
Feenstra, M ;
Veltkamp, M ;
van Kuik, J ;
Wiertsema, S ;
Slootweg, P ;
van den Tweel, J ;
de Weger, R ;
Tilanus, M .
TISSUE ANTIGENS, 1999, 54 (03) :235-245
[6]   Microsatellites in the HLA region: 1999 update [J].
Foissac, A ;
Salhi, M ;
Cambon-Thomsen, A .
TISSUE ANTIGENS, 2000, 55 (06) :477-509
[7]   Microsatellites in the HLA region: 1998 update [J].
Foissac, A ;
Cambon-Thomsen, A .
TISSUE ANTIGENS, 1998, 52 (04) :318-352
[8]   FREQUENT LOSS OF HETEROZYGOSITY ON CHROMOSOME-6 IN HUMAN OVARIAN-CARCINOMA [J].
FOULKES, WD ;
RAGOUSSIS, J ;
STAMP, GWH ;
ALLAN, GJ ;
TROWSDALE, J .
BRITISH JOURNAL OF CANCER, 1993, 67 (03) :551-559
[9]   Implications for immunosurveillance of altered HLA class I phenotypes in human tumours [J].
Garrido, F ;
RuizCabello, F ;
Cabrera, T ;
PerezVillar, JJ ;
LopezBotet, M ;
DugganKeen, M ;
Stern, PL .
IMMUNOLOGY TODAY, 1997, 18 (02) :89-95
[10]  
Gupta PK, 1997, CANCER RES, V57, P1188